Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.76 |
| ▸ | AHCY | P23526 | 7/20 | 0.68 |
| ▸ | ADORA2A | P29274 | 7/20 | 0.64 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.64 |
| ▸ | EGFR | P00533 | 1/20 | 0.54 |
| ▸ | PI4KA | P42356 | 2/20 | 0.52 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.52 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.52 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | ADCY5 | O95622 | 2/20 | 0.50 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Eritadenine SCHEMBL3076264 | 1.00 | ALDH1A1 (0.76) | ALDH1A1AHCYADORA2AADORA1EGFR | |
| Eritadenine SCHEMBL27715791 | 1.00 | ALDH1A1 (0.76) | ALDH1A1AHCYADORA2AADORA1EGFR | |
| SCHEMBL2049963 | 0.86 | ALDH1A1 (1.00) | ALDH1A1AHCYADORA2AADORA1EGFR | |
| SCHEMBL2049962 | 0.86 | ALDH1A1 (1.00) | ALDH1A1AHCYADORA2AADORA1EGFR | |
| SCHEMBL2049965 | 0.86 | ALDH1A1 (1.00) | ALDH1A1AHCYADORA2AADORA1EGFR | |
| SCHEMBL2270408 | 0.83 | ALDH1A1 (0.75) | ALDH1A1AHCYADORA2AADORA1EGFR | |
| SCHEMBL10683911 | 0.83 | ALDH1A1 (0.75) | ALDH1A1AHCYADORA2AADORA1EGFR | |
| SCHEMBL6532875 | 0.82 | ALDH1A1 (0.73) | ALDH1A1AHCYADORA2AADORA1EGFR | |
| SCHEMBL11474105 | 0.82 | AHCY (0.76) | ALDH1A1AHCYADORA2AADORA1PI4KA | |
| SCHEMBL16603993 | 0.81 | AHCY (0.85) | ALDH1A1AHCYADORA2AADORA1PI4KA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1413 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116369504-B | Lentinus edodes extract rich in lentinula edodes purine, lentinula edodes residue proteolytic peptide liquid, and preparation method and application thereof | 湖北浩伟科技股份有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-116369504-A | Lentinus edodes extract rich in lentinula edodes purine, lentinula edodes residue proteolytic peptide liquid, and preparation method and application thereof | 湖北省农业科学院农产品加工与核农技术研究所 | 2023-07-04 | — | — | CN | claimed |
| EP-4101291-A1 | METHOD FOR PREPARING VITAMIN D DERIVED FROM SHIITAKE MUSHROOMS | Kim, Jeong Ok (KR) | 2022-12-14 | — | — | EP | claimed |
| CN-115066174-A | Preparation method of vitamin D from shiitake mushroom | 金正玉 | 2022-09-16 | — | — | CN | claimed |
| CN-109511939-A | A kind of baked chicken flavor essence of allotment type Mo Gu and preparation method thereof | 天津春发生物科技集团有限公司 | 2019-03-26 | — | — | CN | claimed |
| CN-108669177-A | A kind of lentinacin cake and preparation method thereof | 友臣(福建)食品有限公司 | 2018-10-19 | — | — | CN | claimed |
| CN-107232562-A | A kind of compressed type composite beef flour soup and preparation method thereof | 尹连花 | 2017-10-10 | — | — | CN | claimed |
| CN-105136964-B | A kind of method for detecting lentinacin and mushroom alcohol | 上海市农业科学院 | 2017-09-26 | — | — | CN | claimed |
| US-20160367645-A1 | LYSOSOMAL ACID LIPASE THERAPY FOR NAFLD AND RELATED DISEASES | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2016-12-22 | — | — | US | claimed |
| CN-106070501-A | A kind of precious mushroom moon cake and preparation method thereof | 开平健之源保健食品有限公司 | 2016-11-09 | — | — | CN | claimed |
| CN-1089086-C | Luminandide medicine | MILLS RANDELL L (US) | 2002-08-14 | — | — | CN | claimed |
| US-6365186-B1 | ADMINISTERING TO PATIENT UNSUBSTITUTED POLYDIALLYLAMINE POLYMER AND CHOLESTEROL-LOWERING AGENT IN THERAPEUTICALLY EFFECTIVE AMOUNT | GELTEX PHARMACEUTICALS, INC. | 2002-04-02 | — | — | US | claimed |
| WO-2001037680-A1 | FOOD COMPOSITIONS AND METHODS OF PREPARING THE SAME | ERITOCAP OY (FI) | 2001-05-31 | — | — | WO | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000069445-A1 | COMBINATION THERAPY FOR TREATING HYPERCHOLESTEROLEMIA | GELTEX PHARMACEUTICALS, INC. (US) | 2000-11-23 | — | — | WO | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-0414730-B1 | Chemical Compounds and pharmaceutical compositions capable of releasing a drug | MILLS RANDELL L (US) | 1999-12-15 | — | — | EP | claimed |
| CN-1178122-A | Multifunctional nutrient liquid for banting and preventing cancers | QUEYUAN INTERNATIONAL BIOLOG E (CN) | 1998-04-08 | — | — | CN | claimed |
| CN-1122206-A | Producing method for pine kernel and xianggu mushroom soy sauce and its product | SUN XIYUN (CN) | 1996-05-15 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160367645-A1 | LYSOSOMAL ACID LIPASE THERAPY FOR NAFLD AND RELATED DISEASES | LIPC, PNLIP, LIPA | ALDH1A1 1049/4885AHCY 1101/4885ADORA2A 4378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.